Biopreservation Market

Global Biopreservation Market is valued at USD 1.62 Billion in 2021 and expected to reach USD 5.71 Billion by 2028 with a CAGR of 19.7% over the forecast period.

Global Biopreservation Market: Global Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2029: The development of the market is expected to be driven by rising R&D spending. Furthermore, increasing number of bio-banks for the storage  of biopharmaceuticals that may be employed in many forms of medicinal research is expected to boost market growth over the forecast period.

Scope-

Biopreservation is a process of preserving biological material including saliva, plasma, and pure DNA. This method mainly extends the storage life of the biospecimens and guarantees their integrity and cleanliness. Cells, organs, and tissues are stored via bio-preservation, which is also increasingly being utilized to ensure the security of foodstuffs.

Refrigerators, commodities, liquid nitrogen, media, and laboratory data administration systems make up the equipment. To maintain the functioning and purity of different therapeutic trial substances, sperm, eggs, embryos, and others, biopreservation is used in several healthcare institutions and settings. Biobanking, which is a kind of biopreservation, is often used in medical research pertaining to personalized treatment and genomics exploration.

CoVID-19 Outbreak Impact-

Throughout the COVID-19 outbreak, the market had significant setbacks due to, supplier chain problems, a lack of raw resources, and difficulties conducting research. The development of innovative biologics and vaccine innovations has, nevertheless, been driven by the outbreak. These elements will likely lead to more options for the production and conservation of biologics, which will raise the need for biopreservation.

Key Players-

The primary players characterizing the competitive terrain of this marketplace are -

• BioLife Solutions
• Azenta US Inc.
• LabVantage Solutions Inc.
• Biomatrica Inc.
• PrincetonCryo
• MVE Biological Solutions
• Taylor-Wharton
• Thermo Fisher Scientific Inc.
• Stirling Ultracold
• Worthington Industries Inc.
• X-Therma Inc.
• others

Segmentation-

By Product:

• Equipment

  • Refrigerators
  • Freezers

  • Consumables

    • Straws
    • Vials
    • Microtiter Plates
    • Liquid Nitrogen
    • Bags

  • Media

    • Home-brew
    • Pre-formulated
  • Laboratory Information Management System (LIMS)

By Application:

• Regenerative Medicine

  • Gene Therapy
  • Cell Therapy
  • Others

• Bio- Banking

  • Human Sperms
  • Human Eggs
  • Veterinary IVF
• Drug Discovery

By Cells Providers Volume:

• Tumour Cells
• CD19+
• CD34+
• iPSC
• hESC
• MSC
• Others

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Key Trends-

Increasing demand for customized therapy, Rising Technology Adoption, and Growing Government Funding and Initiatives are Some of the Major Factors Driving the Market Growth

The marketplace for biopreservation is expanding rapidly as a result of the rising demand for customized therapy. Patients diagnosed with rare disorders are treated with personalized medicines. Biobanks, which use biopreservation to store individual tissues and cells, assist in the development of personalized medications. For example, to make it simpler to continue incorporating precision healthcare into Swedish medicine, the Swedish administration committed SEK 220 million to the Swedish federal architecture of Genomic Medicine Sweden (GMS) in September 2021.

It guarantees that everyone has access to more precise diagnostics and specialized treatment. Growth in the need for tailored medications is the reason why these investments are being made. Therefore, the future development of the biopreservation industry is anticipated to be driven by the rising need for customized treatment.

Growing life science need is anticipated to fuel the biopreservation industry throughout the projected timeframe across all geographies. The biopreservation media industry is being driven by developments in the regeneration marketplace and biobanking for curing and managing several chronic illnesses including heart problems and diabetes and degenerative ailments impacting the neurons, bones, as well as joints.

Increasing chronic illnesses worldwide is Expected To Drive Market Growth

The global increase in the incidence of obesity, as well as chronic disorders, is one of the key reasons fueling the market's expansion. The need for biopreservation is rising as more people are being diagnosed with chronic illnesses including diabetes, heart disease, including degenerative ailments impacting the joints, nerves, and ligaments, among others.

According to an updated estimate from the World Health Organization (WHO), cardiovascular illnesses account for more than 17 million fatalities each year, making them the leading cause of mortality globally. According to a different WHO estimate, 650 million individuals worldwide are classified as obese, with around 1.9 billion adults worldwide being overweight.

Over the last ten years, there has been a noticeable increase in chronic illnesses. The healthcare industry is under tremendous pressure to employ improved biospecimen preservation methods as a result of the increase in patient numbers. As a result, biopreservation methods have been widely adopted and used, which has helped the industry expand.

Market Restraints-

Transfer from the Laboratories to the Marketplace is expected to hinder the Market Growth over the Forecast Period

The transfer from the laboratories to the marketplace, however, raises serious problems regarding the conservation and preservation of tissues or cells. Despite the protection, tissue or cell harm is often brought on by the thawing and freezing procedures. This limits the commercial viability of biopreservation. Specific cell cryopreservation is considerably simpler and easier than tissues cryopreservation. When cells are frozen and thawed, they suffer damage that is related to the physicochemical as well as biophysical modifications that take place during cryopreservation. These procedures could impede market expansion.

Geographical Landscape-

North America is Expected to Capture a Major Share in the Global Biopreservation Market

Geographically, North America dominated the market and is expected to maintain its position throughout the forecast period. This is due to the development of cutting-edge medicines and the growth of biomedical studies. Technological developments, rising product clearance rates, collaborations, and takeovers by major companies are all contributing to the market's expansion.

For instance, CryoStore FLEX Freezing Bag was introduced in the United States and Europe in February 2022 by OriGen Biomedical Inc., a multinational medical equipment producer of cryopreservation, tissue culture, as well as breathing solutions. The CryoStore FLEX Bag provides the multi-chamber adaptability of small-volume dosage systems and is intended for the cryopreservation of plasma constituents.

The biopreservation industry in the U.S. is anticipated to increase as a result of the existence of governmental organizations and numerous biobanking institutions, which are promoting the use of biopreservation methods. In February 2021, the US National Institutes of Health (NIH) unveiled a $1.15 billion, four-year program to fund researchers who would monitor patients' recovery from COVID-19 infections and operate a biospecimen repository.

Biobanks also assist the nation's clinical trial procedures and translational academic initiatives, expanding the reach of biopreservation technology. These elements could cause the biopreservation business in the US to expand profitably.

Asia Pacific to Grow At The Fastest Pace Over The Forecast Period

A rising population increased knowledge of stem cell preservation, and ongoing advancements in the healthcare industry due to government financing are all factors that will make Asia-Pacific the area with the fastest-growing biopreservation industry over the projection timeframe. In terms of technology and media demand, developing nations like Indonesia, India, Malaysia, China, Singapore, and Brazil are predicted to contribute to market expansion.

News-

Seattle Children's Therapeutics And Biolife Solutions Partnered To Improve Biopreservation And Closed-System Production

On January 14^th, 2022; Seattle Children's Therapeutics as well as BioLife Solutions announced an expanded partnership to improve biopreservation and closed-system production with the incorporation of Sexton's AF-500 cell processing technologies. In order to treat pediatric illnesses, particularly pediatric cancer, the closed-system cell therapy products will be deployed at VectorWorks, Seattle Children's Therapeutics' newest lentiviral vector production plant.

B Medical Systems S.á r.l. as well as its affiliates B Medical Engaged Into A Formal Agreement With Azenta, Inc

On June 15^th, 2022; B Medical Systems S.á r.l. as well as its affiliates B Medical, a global leader in temperature-controlled warehousing and transport technologies that allow the distribution of life-saving therapies throughout the world, inked  a formal agreement with Azenta, Inc. Azenta's cold chain capabilities are enhanced by this purchase, which brings distinct solutions for the safe and traceable transportation of temperature-sensitive specimens.

Avantor, Inc., Begun Work On A Distribution Facility That Will Enable Biopharmaceutical Firms In Ireland Get Faster Access To Vital Production Supplies

On February 11^th, 2022; Avantor, Inc., a leading worldwide distributor of mission-critical goods and services to clients in the biological sciences, sophisticated technology, and applied technologies sectors, has. The facility will greatly expand distribution capability to fulfill the expanding demand for manufacturing ingredients by Ireland's biopharmaceutical sector.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 1.62 Billion
Base year considered	2021
Forecast Period CAGR %:	19.7%
Market Size Expected in 2028:	USD 5.71 Billion
Tables, Charts & Figures:	175
Pages	300
Companies	BioLife Solutions, Azenta US, Inc., LabVantage Solutions, Inc., Biomatrica, Inc., PrincetonCryo, MVE Biological Solutions, Taylor-Wharton, Thermo Fisher Scientific, Inc., Stirling Ultracold, Worthington Industries, Inc., X-Therma Inc., and others
Segments Covered	By Product, By Application, By Cells Providers Volume
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa